Introduction
Doxorubicin (DOX) is a broad-spectrum and effective chemotherapeutic agent, but its use in oncologic practice is limited by dose-dependent cumulative cardiotoxicity, which results in irreversible and often fatal drug-induced congestive heart failure (Octavia et al., 2012) . DOX-induced cardiotoxicity is mediated in large part by overproduction of reactive oxygen species (ROS), resulting in oxidative stress and cardiac tissue injury (Olson and Mushlin, 1990 ). 4-Hydroxy-2-nonenal (HNE) is an Įȕ-unsaturated hydroxyalkenal, and a highly electrophilic lipid peroxidation product formed during oxidative stress (Eckl et al., 1993) . HNE exerts its toxicity primarily by reacting with tissue nucleophiles, including cellular proteins and glutathione (GSH) (Eckl et al., 1993) . The conjugation of HNE with GSH (GS-HNE) forms a less toxic metabolite, but its intracellular accumulation can still generate toxicity due to end-product inhibition of relevant glutathione-S-transferases (GST), with subsequent accumulation of HNE and ensuing toxicity (Diah et al., 1999; Renes et al., 2000) .
Multidrug resistance associated protein 1 (Mrp1/Abcc1), a member of subfamily C of the ATP-binding cassette (ABC) transporters, mediates ATP-dependent efflux of a wide range of chemotherapeutic drugs, such as epipodophyllotoxins and Vinca alkaloids, either by transporting them with reduced GSH or as GS-, glucuronide, or sulfate conjugates (Cole et al., 1992) . While human MRP1 mediates efflux of anthracyclines such as DOX, murine Mrp1 does not, due to key differences in the amino acid sequences (Zhang et al, 2001 ). Mrp1 also effluxes many endogenous compounds, including GSH and GSSG (Cole et al., 1992) , and tissues of Mrp1-/-mice This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on September 9, 2015 as DOI: 10.1124 at ASPET Journals on October 15, 2017 jpet.aspetjournals.org Downloaded from JPET #225490 6 have higher GSH levels, attributed to loss of Mrp1-/-mediated efflux (Lorico et al., 1997) . We therefore questioned whether deletion of Mrp1 and the resultant increase in intracellular GSH might protect the heart against DOX-induced oxidative stress. Wojnowski et al, (2005) reported that patients with a single nucleotide polymorphism (SNP) in MRP1, G671V, have an increased risk of DOX-induced cardiotoxicity. We expressed this G671V variant in HEK293 cells, and demonstrated that its Vmax for efflux of GS-HNE was decreased 85% relative to wild-type MRP1.We also showed that Mrp1 is the sole mediator of ATP-dependent transport of GS-HNE in mouse cardiac sarcolemmal vesicles (Jungsuwadee et al, 2012) . Taken together, these data suggested that Mrp1 could play a role in oxidative stress-induced injury in cardiac tissue, and led us to postulate that deficiency of Mrp1 enhances DOX-induced cardiotoxicity due to intracellular accumulation of GS-HNE. Here we assessed the potential cardioprotective role of Mrp1 by comparing cardiac injury induced by a single dose of DOX in Mrp1 deficient mice (Mrp1-/-) to that in wild-type mice (WT) and quantitated retention of GS-HNE, the cellular antioxidants GSH, GSSG, and the expression of antioxidant proteins in treatment-naïve WT and Mrp1-/-mice and after treatment with saline or DOX. Surprisingly, deletion of Mrp1 did not increase GS-HNE in heart of treatment-naïve Mrp1-/-vs WT mice; further, GS-HNE was only modestly increased in Mrp1-/-vs WT heart following DOX treatment. Nevertheless, despite increased levels of GSH in the heart, DOX induced significantly more nuclear injury in Mrp1-/-vs WT mice. Kentucky (Lexington, KY). Ten to twelve-week-old Mrp1-/-male mice and their WT age-matched littermates (n = 6-8) were treated with normal saline (7.5 mL/kg), or DOX (15 mg/kg) intravenously, and heart tissues removed 72 h after treatment for analyses.
0RUSKRPHWULF 4XDQWL¿FDWLRQ E\ (OHFWURQ 0LFURVFRS\
Heart tissue from the left ventricle was ¿xed, embedded, and processed for electron microscopy as described (Chaiswing et al., 2004) . Embedded blocks from each mouse were sectioned and transferred to copper grids. Only longitudinal sections of cardiac muscle were used for examination. Grids were observed in an electron microscope (Hitachi H-600) operated at 75 kV. Random sampling was DFKLHYHG E\ VFDQQLQJ WKH JULG DW ORZ PDJQL¿FDWLRQ VR WKDt cell injury was not apparent, yet gross sample artifacts (folds in tissues, dust particles, etc.) could be avoided.
Grids were systematically scanned from top to bottom and from left to right so that photographs of entire cardiomyocytes were taken at 8,000x PDJQL¿FDWLRQ HYHU\ -JULG ¿HOGV. Sixty individual cardiomyocytes were photographed for each treatment group. All quantitative ultrastructural data (mitochondrial, cytoplasmic and nuclear damage) were analyzed from the same cardiomyocyte. Mitochondrial 
Preparation of heart ventricle for biochemical assays
The heart was extracted from the chest cavity, atrium, attached fat tissue and and bovine serum albumin as standard.
Immunoblot assays. For detection of catalase, GCLc, GCLm, GR, Cu, Zn-SOD, MnSOD, and EC-SOD, ventricle homogenates were fractionated on 4-12% SDS-PAGE gels. For detection of expression of Abcb1, sarcolemmal membranes were prepared from the ventricle exactly as described (Jungsuwadee et al, 2006) and 12 proteins fractioned on a 6% SDS-PAGE gel. Proteins were transferred to nitrocellulose membranes, and the blots blocked in TBS/5% nonfat milk/0.1% Tween 20 (pH 7.5) followed by overnight incubation at 4°C with different primary antibodies:
mouse anti-catalase monoclonal antibody (1:3,000), rabbit anti-GCLc polyclonal antibody (1:1,000), rabbit anti-GCLm pAb (1:1000), rabbit anti-GR pAb (1:1,000), rabbit anti-Cu, ZnSOD pAb (1:5,000), rabbit anti-MnSOD pAb (1:5,000), anti-ECSOD pAb (1: 20,000) and anti-Pgp mAb (1:2,000). GAPDH (1:5000) was used as the protein loading control. The membranes were probed with appropriate secondary antibodies conjugated to horseradish peroxidase at room temperature for 1 h, and protein visualized by Enhanced Chemiluminescence Plus (RPN2236, GE Healthcare, UK).
Assay of GSH and GSSG by high pressure liquid chromatography (HPLC). The
HPLC assay for GSH and GSSG is based on that developed by Senft et al (2000) , and used widely (Barajas-Espinosa et al, 2014; Kennedy et al, 2013; Yamazaki et al, 2012; . Mouse heart homogenate was diluted with 0.5 volume of Buffer A containing 15% metaphosphoric acid and mixed thoroughly, followed by centrifugation at 12,000 rpm for 15 min at 4°C. For GSH measurement, the supernatant was added to redox quenching buffer (20 mM HCl, 5 mM diethylenetriaminepentaacetic acid, and 10 mM ascorbic acid) and then mixed with monobromobimane (MBB; prepared in HPLC-grade acetonitrile) derivatization buffer to yield final concentrations of 30 mM NaOH, 250 mM diethlenetriaminepenta acetic acid, and 2.5 mM MBB (Senft et al, 2000) .
Derivatization of GSH with MBB was
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GSSG was derivatized by the same method following pretreatment of the heart homogenate with 0.5 mM N-ethylmaleimide to conjugate free GSH and reduction of GSSG to GSH by addition of 5 mM dithiothreitol. The MBB-derivatized samples were centrifuged and the supernatants assayed for thiol-bimane fluorescence by HPLC using a linear gradient from 0-100% solvent B (50% methanol and 0.25% acetic acid in water) in solvent A (10% methanol and 0.25% acetic acid in water) within 28 min at a flow rate of 0.8 mL/min with fluorescence detection at Ex 370 /Em 485 , detected with WKH :DWHUV 0XOWL Ȝ IOXRUHVFHQFH GHWector as described (Senft et al., 2000) .
Fluorescence intensities versus time of elution were quantified using Waters Breeze chromatography software v.3.2 (Waters Corporation, Milford, USA) and peak areas integrated and converted to nmol equivalents according to the GSH and GSSG standard curves. We used authentic GSH (G-4251, Sigma-Aldrich) and GSSG (150568, Sigma-Aldrich) to develop the standard curves for these assays, and the quantitated experimental samples had the same retention times for GSH and GSSG as the authentic standards, thus ensuring that any contaminating side-products were not included in the assay. GSH/GSSG ratios in treatment-naïve and saline treated WT hearts were comparable to those obtained by others in normal mouse heart (GSH/GSSG = 26, Watanabe et al, 2013; GSH/GSSG = 18, Han et al, 2009 ), thus supporting the validity of the assay.
Statistical analysis
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Results

DOX induced ultrastructural damage in mouse heart
We used a morphometric analysis of electron micrographs of the heart following saline vs DOX treatment to identify potential differences in WT vs Mrp1-/-mice. This ultrastructural pathological examination demonstrated that DOX treatment caused significant damage to cardiomyocytes. Cytoplasm, mitochondrial and nuclear injury predominated in both genotypes following DOX treatment. Loss of mitochondrial cristae and swollen mitochondria were exceedingly rare in saline-treated mice, whereas DOX-treated mice showed dramatic subcellular changes, including mitochondrial vacuolization, the SUHVHQFH RI P\HOLQ ¿JXUHV cytoplasmic vacuolization, myofibril disarray, and mitochondrial degeneration ( Figure. 1A-D) . DOX-induced mitochondrial damage was greater than cytoplasmic damage in both genotypes.
Total damaged areas of cardiac tissue were comparable between WT and Mrp1-/-mice following DOX treatment, and were significantly different than that of saline controls ( Figure. 
GSH and GSSG concentration in mouse heart
GSH is the most abundant endogenous antioxidant that plays an important role in protecting cells from oxidative damage. A decrease in the GSH/GSSG ratio provides a measure of the degree of oxidative stress in a biological system. Here we examined heart from treatment-naïve mice and following treatment with saline or DOX, and quantitated GSH and GSSG levels to assess oxidative stress. Basal levels of GSH in treatment-naïve mice were significantly higher in heart of Mrp1-/-vs WT mice ȝPROJ SURWHLQ YV ȝPROJ SURWHLQ p = 0.0002), whereas there was no difference in the GSSG levels, such that the baseline GSH/GSSG ratio in Mrp1 -/-mice was significantly (p = 0.0015) higher than that in WT mice ( Figure. 3A) . GSH concentrations in heart of Mrp1 -/-mice remained significantly higher than WT mice following saline and DOX treatment (Bonferroni adjusted p = 0.0204 and 0.0028, respectively) ( Figure. 3B ). GSSG levels were comparable 72 h after DOX treatment in WT and Mrp1 -/-hearts ( Figure. 3B ), as were the GSH/GSSG ratios.
GS-HNE in mouse heart
Oxidative stress mediated by DOX causes lipid peroxidation with HNE as one of the major toxic lipid metabolites. The highly electrophilic HNE reacts rapidly with GSH to form GS-HNE. Despite its decreased reactivity, GS-HNE remains toxic and requires elimination by an efflux transporter. We measured GS-HNE (nmol/g heart tissue) in heart of treatment-naïve mice using LC-MS/MS, and found that while GS-HNE was significantly higher in treatment-naïve WT vs Mrp1 whereas GS-HNE in Mrp1-/-mice remained unchanged following DOX, so that GS-HNE detected in the heart of Mrp1-/-mice was significantly higher than that in WT mice (p < 0.0001, Figure 4B ).
Expression of antioxidant proteins
Under oxidative stress conditions, cells typically respond by increasing biosynthesis and maintenance of GSH, as shown in Figure 3 , following DOX treatment in Mrp1-/-heart. We analyzed protein expression of GCLc, GCLm, and GR in heart isolated from WT and Mrp1 -/-mice 72 h after treatment with saline or DOX.
DOX significantly increased the expression of GCLm in both WT and Mrp1-/-mice compared with saline controls (p < 0.05). There were no differences in either GCLc or GR protein expression in WT or Mrp1 -/-mice treated with saline or DOX ( Figure 5 ).
The expression of several antioxidant enzyme genes is altered following DOX treatment (Li et al., 2000) . Therefore, we examined protein expression of catalase, Cu, ZnSOD, MnSOD, and ECSOD in WT and Mrp1-/-mice following saline or DOX treatment. When compared with saline-treated mice, catalase expression increased in response to DOX treatment in both WT and Mrp1-/-mice ((p < 0.05, Figure 5 ), however there was no statistically significant difference observed between genotypes.
There was also no change in expression of any of the three isoforms of SOD enzymes after DOX treatment, regardless of genotypes ( Figure 5 ). 
Discussion
The present study clearly demonstrates that DOX-induced acute cardiac toxicity was significantly exacerbated in Mrp1-/-mice. While morphometric analysis of electron micrographs of the heart showed significant damage to the mitochondria and the cytoplasm following DOX treatment, consistent with previous findings (Yen et al, 1996) , this injury was not different between the two genotypes. In contrast, the nucleus showed significantly more damage following DOX treatment of Mrp1-/-mice, with fragmentation of the nucleolus, segregation of granular and fibrillar components, and condensation of nucleoli with compacted chromatin. The nucleolus is the primary site of transcription, assembly and processing of cellular RNA (Antoniali et al., 2014) , with a tripartite organization that reflects the different steps of ribosomal biogenesis. RNA polymerase I transcription starts in the fibrillar center, with the dense fibrillary component the site of initial stages of pre-rRNA processing and a granular component involved in the late processing steps. DOX has been shown to inhibit ribosomal RNA synthesis at the initial step of rRNA transcription, which in turn leads to nucleolar disintegration (Burger et al., 2010) . The present findings of nucleolar disintegration and nuclear injury are consistent with DOX actions, and indicate a significantly greater susceptibility to injury in Mrp1-/-mice. While we also observed a greater increase in cytoplasmic injury following saline treatment in Mrp1-/-vs WT mice (Figure 1 ), such an increase was not observed in an earlier study that demonstrated a significant increase in nuclear injury in DOX-treated Mrp1-/-vs WT mice (Coy, 2012) , consistent with the present studies. 
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While the mechanism by which DOX induces cardiac injury is multifactorial, it is well accepted that DOX-induced oxidative stress is a significant contributor to cardiotoxicity. DOX is an anthracycline that readily binds to cardiolipin and is thus concentrated in mitochondria, where its quinone moiety undergoes a one-electron reduction to form the semiquinone, which in turn reduces molecular oxygen, generating the superoxide radical (Olson and Mushlin, 1990 countered by a number of antioxidants in the heart, with GSH serving as a major antioxidant. GSH in Mrp1-/-mice was significantly elevated, consistent with previous reports demonstrating that loss of Mrp1 and Mrp1-mediated efflux increases tissue GSH (Lorico et al., 1997) . GSH is the most abundant endogenous thiol-containing antioxidant molecule and can directly scavenge strong oxidants such as O 2 •-and peroxynitrite in a non-enzymatic manner. GSH is also a co-factor for GSTs that catalyze conjugation with electrophilic products of lipid peroxidation such as HNE and serves as a co-factor for glutathione peroxidase in the reduction of H 2 O 2 (Backos et al, 2012) . Thus, maintenance of GSH and a stable GSH/GSSG ratio are beneficial in maintaining low cellular levels of ROS, decreased lipid peroxidation and production of HNE. The decreased GS-HNE detected in treatment-naïve Mrp1-/-mice may thus reflect the antioxidant protection provided by increased GSH, resulting in lower basal levels of lipid peroxidation. Even after DOX treatment, GSH levels remained that occurs to the same extent in both genotypes. However, whereas GSH and GSSG return to that in saline controls in WT cells within 2 -4 h, in Mrp1-/-cells, GSSG remains elevated from 15 min to 24 h and GSH rapidly returns to control levels at 1 h, continues to increase and is significantly increased and stable from 12 to 24 h.
The GSH/GSSG ratio is thus significantly decreased at 15 min, recovers and does not differ between genotypes. These data are consistent with the findings in heart tissue ( Figure 3) , where GSH is significantly greater in DOX-treated Mrp1-/-mice vs WT mice at 72h, and the GSH/GSSG ratio does not differ between treatment or genotype.
The rapid recovery of GSH implies a more rapid rate of synthesis.
Glutamate-cysteine ligase (GCL) catalyzes the rate limiting step in de novo GSH synthesis, and is composed of two subunits, a catalytic subunit, GCLc, and a modifier subunit, GCLm, that interacts with GCLc to greatly enhance its catalytic efficiency (Christopher et al., 2008) . Mice deficient in GCLm exhibit decreased GSH levels and are more susceptible to oxidative stress (Cole et al., 2011) . DOX treatment significantly increased expression of GCLm to a similar extent in WT and Mrp1-/-mice.
Increased GSH synthesis coupled with decreased efflux presumably account for the greater GSH levels following DOX treatment in Mrp1-/-miceand is undoubtedly part of the adaptive response to loss of expression of Mrp1. 
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We also examined the effects of chronic DOX treatment in WT and Mrp1-/-mice on GSH homeostasis (Zhang et al, 2015) . Mice were treated with saline or 2 mg/kg DOX twice a week for 5 weeks, and GSG and GSSG determined in heart 48 h and 2 weeks following the last treatment. In this chronic treatment model, GSH and the GSH/GSSG ratio were decreased at 48 h, but had recovered by 2 weeks after treatment (Zhang et al, 2015) . These data are consistent with a decrease in GSH and GSH/GSSG upon oxidative stress that in turn triggers activation of the antioxidant stress response system to increase GSH synthesis and restore a normal GSH/GSSG ratio. Taken together, these data imply that restoration of redox homeostasis has occurred by 72 h after a single DOX dose, and had not yet occurred at 48 h but was apparent 2 weeks after chronic DOX treatment.
Amongst the many products of lipid peroxidation, including isoprostanes (Milne et al, 2011) , HNE has been most extensively studied because of its abundance and high reactivity with cellular nucleophiles, including DNA, proteins and lipids (Eckl et al, 1993) . HNE peaks at 2 h following DOX administration to rats, then declines to baseline levels within 8 -24 h (Luo et al, 1997) . In mice, HNE increases as early as 3 h, peaks at 6 h and subsequently declines at 24 h (Chaiswing et al 2004) . While we anticipated increased HNE-adduction of proteins in Mrp1-/-mice following DOX, we did not detect any differences in HNE-adducted proteins in heart homogenate between treatment or genotypes 72 h following DOX treatment (data not shown).
However, we detected significantly increased isoprostanes in heart 72 h after DOX, Following perfusion of isolated rat heart with HNE, Ishikawa et al (1986) demonstrated a depletion of intracellular GSH accompanied by an increase in GS-HNE efflux into the perfusate by a saturable process, indicating formation of a GSH conjugate subsequently effluxed by a transporter. In mouse heart, Mrp1 is the primary efflux transporter of GS-HNE, as shown using sarcolemmal vesicles (Jungsuwadee et al, 2012) . While we anticipated an increased retention of GS-HNE in heart of Mrp1-/-mice relative to WT mice following DOX treatment, the basal level of GS-HNE in treatment-naïve Mrp1-/-mice was significantly lower than that in their WT counterparts as discussed above. In further unexpected results, GS-HNE was decreased in heart following DOX treatment of WT mice. We demonstrated that DOX treatment increases expression of Mrp1 protein in heart that is maximal at 6 h (Jungsuwadee et al., 2006) ; the decreased GS-HNE detected in DOX-treated WT mice may therefore reflect the induction of Mrp1 expression by DOX and its increased efflux. GS-HNE levels were not different in saline-vs DOX-treated hearts from Mrp1-/-mice, so that GS-HNE in DOX treated Mrp1-/-mice was modestly, but significantly greater than that in DOX-treated WT mice. Again, these data suggest that complete loss of Mrp1-mediated GS-HNE efflux contributes to its increased retention in Mrp1-/-mice. 
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In contrast, following chronic DOX treatment, GS-HNE was somewhat elevated 48 h after DOX and significantly increased 2 week after the last dose of DOX in both WT and Mrp1-/-mice (Zhang et al, 2015) . These data imply that the early increase in Mrp1 expression is not sufficiently long-lasting to sustain low GS-HNE levels in WT mice following 5 weeks of DOX treatment. Indeed, immunoblots of heart from salineand DOX-treated mice at 48 h and 2 weeks after chronic DOX treatment showed no differences in expression of Mrp1 (Zhang et al, 2015) .
In addition to conjugation with GSH, HNE can be detoxified by oxidation to 4-hydroxy-2-nonenoic acid and reduced to 1,4-dihydroxy-2-nonene. GS-HNE can be similarly oxidized and reduced, and can also be metabolized to mercapturic acid conjugates (Alary et al., 2003; Volkel et al, 2005) . Whether these HNE and GS-HNE metabolites are substrates for Mrp1, and how their formation is affected by loss of Mrp1 expression is not known.
While DOX is not a substrate for murine Mrp1, we investigated whether other ABC efflux transporters might be upregulated in Mrp1-/-mice. Expression of Abcb1 in sarcolemmal membranes from mouse heart was not different between treatment or genotype (Supplemental Figure 2) . We also quantitated DOX in heart of WT and Mrp1-/-mice at 6, 12 and 24 h following DOX administration and found no differences in DOX retention, consistent with the lack of changes in Abcb1 expression in these mice (Supplemental Figure 3) . Finally, we examined expression of Abcb1 and (Zhang et al, 2015) .
In summary, the important and novel finding provided by these studies is demonstration that DOX causes significantly greater nuclear injury in the heart of Mrp1-/-vs WT mice, despite essentially identical concentrations of DOX, and despite significantly higher concentrations of GSH compared to WT mice. We postulated that retention of GS-HNE, a product of DOX-induced lipid peroxidation, would lead to accumulation of HNE and significantly increase damage to cellular proteins. However, we found only a modest, albeit significant, increase in GS-HNE in DOX-treated Mrp1-/-vs WT mice, and did not detect a significant increase in protein HNE-adducts, thus not supporting this hypothesis. Deletion of Mrp1 clearly perturbed the regulation of GSH due to retention of both GSH and GSSG, and this dysregulation likely contributes to the greater DOX cardiotoxicity in Mrp1-/-mice. These data also suggest that Mrp1 has additional functions other than efflux of these known substrates, and whose loss contribute to toxicity. Thus, the development of MRP1 inhibitors in the treatment of cancer (Ma et al, 2014; Zhang et al, 2014) This article has not been copyedited and formatted. The final version may differ from this version. 
